post

Prostate Cancer 2017: Light at the End of the Tunnel?

  If you follow this blog far enough back you will read early rumblings about the futility of prostate cancer screening.  The last ten years has seen a “slow growth” of international guidelines stating that this is something that we probably should NOT be doing… and yet, it remains one of the most common screening […]

post

UKCTOCS: Ovaries, P-values & Questions

Ovarian cancer is a horrible disease.  It is often asymptomatic until late in its course and then causes a lot of suffering.  This is a disease with an extraordinarily high morbidity and currently has a 5-year survival of only 40%.  So wouldn’t it be excellent if we could find this disease early in it’s course, […]

post

Clinical Case 117: Cancer Fishin’

OK – this case is for all the GPs and Internal Medicine types out there.  This is a relatively common scenario…  how do you play it? Here’s the case. Bruce is a 53 y.o. accountant.  He is a little overweight at 89 kg (BMI 31).  He is otherwise relatively well, he cycles to the cafe […]

post

Hypercalcemia in a nutshell

Have seen a few patients with hypercalcemia recently and it has gotten me thinking.   It is one of those areas of medicine where the complex endocrine physiology and diseases can seem a bit overwhelming.  When we approach it in a practical sense it is much simpler than the head-spinning Med school lectures left us […]

post

Mammography and pink cricket bats

A new review of the breast cancer screening ( mammography ) literature came out in the Lancet this week.  This is essentially an expert panel reviewing old data – nothing new.  The UK-based panel looked a the data from a number of long-running screening cohort studies and produced a set of round number estimates for the […]